Masahiko Sugitani
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Hepatitis C virus research 13
- Gastroenterology top 5%
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 23
- Hepatitis B Virus Studies 14
-
- Lymphoma Diagnosis and Treatment 9
- Dermatology top 5%
-
- Sarcoma Diagnosis and Treatment 11
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- Pancreatic and Hepatic Oncology Research 6
- Co-authors
- Geneviève InchauspéA. M. PrinceTadatoshi TakayamaMarc NasoffS L ZebedeeNorimichi NemotoKimitoshi KatoMichiko Shindo
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- JapanUnited StatesBangladesh
In The Last Decade
Masahiko Sugitani
126 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 96
- Hepatology 671
- Gastroenterology 114
- Epidemiology 661
- Pathology and Forensic Medicine 226
- Dermatology 95
Countries citing papers authored by Masahiko Sugitani
This map shows the geographic impact of Masahiko Sugitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Sugitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Sugitani more than expected).
Fields of papers citing papers by Masahiko Sugitani
This network shows the impact of papers produced by Masahiko Sugitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Sugitani. The network helps show where Masahiko Sugitani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiko Sugitani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 6 | |
| 3 | 2020 | 22 | |
| 4 | 2017 | 5 | |
| 5 | 2017 | 15 | |
| 6 | Rare sarcomatoid liver carcinoma composed of atypical spindle cells without features of either HCC or ICC: A case report | 2016 | 2 |
| 7 | 2016 | 8 | |
| 8 | 2015 | 1 | |
| 9 | 2013 | 4 | |
| 10 | 2011 | 2 | |
| 11 | 2009 | 1 | |
| 12 | 2007 | 9 | |
| 13 | 2006 | 16 | |
| 14 | 2006 | 15 | |
| 15 | 2002 | 1 | |
| 16 | 2002 | 3 | |
| 17 | 2000 | 5 | |
| 18 | 1998 | 21 | |
| 19 | 1993 | 3 | |
| 20 | 1986 | 0 |
About Masahiko Sugitani
Masahiko Sugitani is a scholar working on Hepatology, Oncology and Epidemiology, having authored 132 papers that have together received 2.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers), Sarcoma Diagnosis and Treatment (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Hepatology (671 citations), Gastroenterology (114 citations) and Epidemiology (661 citations). Masahiko Sugitani has collaborated with scholars based in Japan, United States and Bangladesh. Frequent co-authors include Geneviève Inchauspé, A. M. Prince, Tadatoshi Takayama, Marc Nasoff, S L Zebedee, Norimichi Nemoto, Kimitoshi Kato, Michiko Shindo, Shigeaki Mizuno and Akemi Imaoka. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.